FORWARD FEATURES CALENDAR

Articles and Features

Venture investment in greentech to rise this year, survey finds

Coming off a year that saw severely diminished venture investment and deal volume in 2009, the venture capital community appears optimistic that a rebound will occur this year, with a prominent focus on the greentech sector, according to a survey by KPMG. In polling 200 venture capitalists, investors, entrepreneurs and

Clifford Chance advises Bridgepoint on offer for Care UK

Law firm Clifford Chance is advising Bridgepoint and newly incorporated company Warwick Bidco on the GBP281m recommended offer for health and social care provider Care UK. The transaction is the second Clifford Chance has advised Bridgepoint on in recent weeks, following on from the private equity house’s GBP257m acquisition of

Due diligence key to private equity outperformance, says Bain

A superior due diligence process followed by a quick transition to active owner involvement will be key to generating exceptional returns from private equity funds, according to a report by business consulting firm Bain. The research finds that new buyout funds formed and new investments made over the next three-to-five

Linklaters advises Triton on acquisition of Ambea

Law firm Linklaters has advised Triton on the EUR850m (USD1.1bn) acquisition of Ambea from private equity firm 3i. Ambea is a provider of healthcare and care services in the Nordic region and is one of the largest European healthcare service providers. The transaction is one of the largest leveraged buyouts

Novo Growth Equity leads GBP65m investment in Archimedes

Archimedes Pharma has raised GBP65m in a funding round led by new investor Novo Growth Equity, the growth equity fund of Novo A/S of Denmark. This deal is believed to be Europe’s biggest single fund raising round for a bio-pharma company in 15 years.   It is also reported to

Venture capital firms sell stake in CoTweet to ExactTarget

A group of venture capital firms has sold its stake in CoTweet, a web-based collaboration platform, to ExactTarget, a provider of on-demand email marketing software solutions. The firms include Baseline Ventures, Founders Fund Management, First Round Capital, Maples Investments, Freestyle Capital and SV Angel. After the completion of the transaction,

Aros Capital Nicolai Borcher Hansen

Aros Capital to launch altruistic investment fund

Aros Capital Partners, an Anglo Danish investment manager, is launching a UK-managed global altruistic opportunities fund in the second quarter of 2010. The fund, called Aros Altru, aims to challenge the notion that social benefits are a trade off with commercial returns by offering equity-like returns to its investors.  

Drugs 2

YA Global invests up to USD10m in Lotus Pharmaceutical

Lotus Pharmaceutical has entered into a USD10m standby equity distribution agreement with YA Global Master SPV, a fund managed by Yorkville Advisors of New Jersey. Yorkville’s Hong Kong office advised on the transaction.   Lotus engages in the production, trade and retail of pharmaceutical products in the People’s Republic of

Pierpont launches as a government securities broker

Pierpont Securities has launched as a government securities broker dealer with USD220m in capital and investor partnerships with two equity investors, Stone Point Capital and General Atlantic. Stone Point Capital, through its fund Trident IV, and General Atlantic have each committed USD100m in capital and Pierpont principals have invested an

Events

12 November, 2026 – 5:00 pm

Directory Listings